ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,163,000 | -73.0% | 58,556 | -59.5% | 0.44% | -69.4% |
| Q1 2022 | $4,312,000 | -13.4% | 144,546 | -32.4% | 1.43% | -5.1% |
| Q4 2021 | $4,982,000 | -25.2% | 213,913 | +0.2% | 1.50% | -29.3% |
| Q3 2021 | $6,661,000 | -28.7% | 213,493 | -19.6% | 2.12% | -8.6% |
| Q2 2021 | $9,344,000 | -1.2% | 265,616 | -1.0% | 2.32% | +21.0% |
| Q1 2021 | $9,459,000 | -28.8% | 268,346 | -24.2% | 1.92% | -29.4% |
| Q4 2020 | $13,286,000 | -16.8% | 354,210 | -26.0% | 2.72% | -14.0% |
| Q3 2020 | $15,972,000 | – | 478,624 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |